Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 79

1.

Role of the U.S. Food and Drug Administration in the regulatory management of human listeriosis in the United States.

Klontz KC, McCarthy PV, Datta AR, Lee JO, Acheson DW, Brackett RE.

J Food Prot. 2008 Jun;71(6):1277-86.

PMID:
18592761
2.

Dietary supplement-induced vitamin D intoxication.

Klontz KC, Acheson DW.

N Engl J Med. 2007 Jul 19;357(3):308-9. No abstract available.

PMID:
17634473
3.

Foodborne infections.

Acheson DW.

Curr Opin Gastroenterol. 1999 Nov;15(6):538-45.

PMID:
17024004
4.

In vivo transduction of an Stx-encoding phage in ruminants.

Cornick NA, Helgerson AF, Mai V, Ritchie JM, Acheson DW.

Appl Environ Microbiol. 2006 Jul;72(7):5086-8.

5.

Characteristics of persistent diarrhea in a community-based cohort of young US children.

Vernacchio L, Vezina RM, Mitchell AA, Lesko SM, Plaut AG, Acheson DW.

J Pediatr Gastroenterol Nutr. 2006 Jul;43(1):52-8.

PMID:
16819377
6.

Diarrhea in American infants and young children in the community setting: incidence, clinical presentation and microbiology.

Vernacchio L, Vezina RM, Mitchell AA, Lesko SM, Plaut AG, Acheson DW.

Pediatr Infect Dis J. 2006 Jan;25(1):2-7.

PMID:
16395094
7.

Prevalence, risk factors, O serogroups, and virulence profiles of Shiga toxin-producing bacteria from cattle production environments.

Renter DG, Morris JG Jr, Sargeant JM, Hungerford LL, Berezowski J, Ngo T, Williams K, Acheson DW.

J Food Prot. 2005 Aug;68(8):1556-65.

PMID:
21132960
8.

Shiga toxin-producing Escherichia coli as a possible etiological agent of chronic diarrhea.

Spacek LA, Hurley BP, Acheson DW, Granok A, Currie A, Doing K, Sears CL.

Clin Infect Dis. 2004 Sep 1;39(5):e46-8. Epub 2004 Aug 11.

PMID:
15356801
9.

Microbial-gut interactions in health and disease. Mucosal immune responses.

Acheson DW, Luccioli S.

Best Pract Res Clin Gastroenterol. 2004 Apr;18(2):387-404. Review.

PMID:
15123077
10.

Preventing foodborne disease--what clinicians can do.

Acheson DW, Fiore AE.

N Engl J Med. 2004 Jan 29;350(5):437-40. No abstract available.

PMID:
14749450
11.

Effect of an oral Shiga toxin-binding agent on diarrhea-associated hemolytic uremic syndrome in children: a randomized controlled trial.

Trachtman H, Cnaan A, Christen E, Gibbs K, Zhao S, Acheson DW, Weiss R, Kaskel FJ, Spitzer A, Hirschman GH; Investigators of the HUS-SYNSORB Pk Multicenter Clinical Trial.

JAMA. 2003 Sep 10;290(10):1337-44.

PMID:
12966125
12.

Shiga toxin 1 triggers a ribotoxic stress response leading to p38 and JNK activation and induction of apoptosis in intestinal epithelial cells.

Smith WE, Kane AV, Campbell ST, Acheson DW, Cochran BH, Thorpe CM.

Infect Immun. 2003 Mar;71(3):1497-504.

13.
14.

Molecular characterization of a serotype O121:H19 clone, a distinct Shiga toxin-producing clone of pathogenic Escherichia coli.

Tarr CL, Large TM, Moeller CL, Lacher DW, Tarr PI, Acheson DW, Whittam TS.

Infect Immun. 2002 Dec;70(12):6853-9.

15.

Shiga toxin interactions with the intestinal epithelium.

Thorpe CM, Hurley BP, Acheson DW.

Methods Mol Med. 2003;73:263-73. Review. No abstract available.

PMID:
12375435
16.

Bacteriophage control of Shiga toxin 1 production and release by Escherichia coli.

Wagner PL, Livny J, Neely MN, Acheson DW, Friedman DI, Waldor MK.

Mol Microbiol. 2002 May;44(4):957-70.

17.

Food Safety: Bovine Spongiform Encephalopathy (Mad Cow Disease).

Acheson DW.

Nutr Today. 2002 Jan-Feb;37(1):19-25.

PMID:
11984426
18.

Hemolytic uremic syndrome: epidemiology, pathophysiology, and therapy.

Andreoli SP, Trachtman H, Acheson DW, Siegler RL, Obrig TG.

Pediatr Nephrol. 2002 Apr;17(4):293-8. No abstract available.

PMID:
11956886
19.
20.

Multivalent inhibition of AB(5) toxins.

Gargano JM, Ngo T, Kim JY, Acheson DW, Lees WJ.

J Am Chem Soc. 2001 Dec 26;123(51):12909-10. No abstract available.

PMID:
11749553
21.

Dangers of empiric oral ciprofloxacin in the treatment of acute inflammatory diarrhea in children.

Acheson DW, Sears CL.

Pediatr Infect Dis J. 2001 Aug;20(8):817-8. No abstract available.

PMID:
11734755
22.
24.

GT160-246, a toxin binding polymer for treatment of Clostridium difficile colitis.

Kurtz CB, Cannon EP, Brezzani A, Pitruzzello M, Dinardo C, Rinard E, Acheson DW, Fitzpatrick R, Kelly P, Shackett K, Papoulis AT, Goddard PJ, Barker RH Jr, Palace GP, Klinger JD.

Antimicrob Agents Chemother. 2001 Aug;45(8):2340-7.

25.

Testing of urinary Escherichia coli isolates for Shiga toxin production.

Thorpe CM, Acheson DW.

Clin Infect Dis. 2001 May 15;32(10):1517-8. No abstract available.

PMID:
11317258
26.
27.

Role for a phage promoter in Shiga toxin 2 expression from a pathogenic Escherichia coli strain.

Wagner PL, Neely MN, Zhang X, Acheson DW, Waldor MK, Friedman DI.

J Bacteriol. 2001 Mar;183(6):2081-5.

28.
29.

Shiga Toxin-Producing Escherichia coli.

Jaeger JL, Acheson DW.

Curr Infect Dis Rep. 2000 Feb;2(1):61-67.

PMID:
11095839
30.

Random transposon mutagenesis of Campylobacter jejuni.

Golden NJ, Camilli A, Acheson DW.

Infect Immun. 2000 Sep;68(9):5450-3.

31.
32.

Shiga toxins.

Acheson DW, Kane AV, Keusch GT.

Methods Mol Biol. 2000;145:41-63. No abstract available.

PMID:
10820715
33.

Quinolone antibiotics induce Shiga toxin-encoding bacteriophages, toxin production, and death in mice.

Zhang X, McDaniel AD, Wolf LE, Keusch GT, Waldor MK, Acheson DW.

J Infect Dis. 2000 Feb;181(2):664-70.

PMID:
10669353
34.
35.

Shiga toxins 1 and 2 translocate differently across polarized intestinal epithelial cells.

Hurley BP, Jacewicz M, Thorpe CM, Lincicome LL, King AJ, Keusch GT, Acheson DW.

Infect Immun. 1999 Dec;67(12):6670-7.

36.

Shiga toxins stimulate secretion of interleukin-8 from intestinal epithelial cells.

Thorpe CM, Hurley BP, Lincicome LL, Jacewicz MS, Keusch GT, Acheson DW.

Infect Immun. 1999 Nov;67(11):5985-93.

37.

Effect of shiga toxin on NaCl transport in rat distal colon.

Krishnan S, Ramakrishna BS, Keusch GT, Acheson DW, Pulimood AB, Mathan M.

Scand J Gastroenterol. 1999 Aug;34(8):777-83.

PMID:
10499478
38.

Shiga toxins do not directly stimulate alpha-granule secretion or enhance aggregation of human platelets.

Thorpe CM, Flaumenhaft R, Hurley B, Jacewicz M, Acheson DW, Keusch GT.

Acta Haematol. 1999;102(1):51-5. No abstract available.

PMID:
10473889
39.

Responses of human intestinal microvascular endothelial cells to Shiga toxins 1 and 2 and pathogenesis of hemorrhagic colitis.

Jacewicz MS, Acheson DW, Binion DG, West GA, Lincicome LL, Fiocchi C, Keusch GT.

Infect Immun. 1999 Mar;67(3):1439-44.

40.
41.

In vivo transduction with shiga toxin 1-encoding phage.

Acheson DW, Reidl J, Zhang X, Keusch GT, Mekalanos JJ, Waldor MK.

Infect Immun. 1998 Sep;66(9):4496-8.

42.

Nomenclature of enterotoxins.

Acheson DW.

Lancet. 1998 Apr 4;351(9108):1003. No abstract available.

PMID:
9546502
43.

Evaluation of the premier EHEC assay for detection of Shiga toxin-producing Escherichia coli.

Kehl KS, Havens P, Behnke CE, Acheson DW.

J Clin Microbiol. 1997 Aug;35(8):2051-4.

44.
45.

Thrombotic thrombocytopenic purpura associated with Shiga toxins.

Keusch GT, Acheson DW.

Semin Hematol. 1997 Apr;34(2):106-16. Review. No abstract available.

PMID:
9109212
46.

Escherichia coli and the hemolytic-uremic syndrome.

Acheson DW, Wolf LE, Park CH.

N Engl J Med. 1997 Feb 13;336(7):515; author reply 515-6. No abstract available.

PMID:
9019657
47.

Translocation of Shiga toxin across polarized intestinal cells in tissue culture.

Acheson DW, Moore R, De Breucker S, Lincicome L, Jacewicz M, Skutelsky E, Keusch GT.

Infect Immun. 1996 Aug;64(8):3294-300.

48.

Comparison of the effects of Shiga-like toxin 1 on cytokine- and butyrate-treated human umbilical and saphenous vein endothelial cells.

Keusch GT, Acheson DW, Aaldering L, Erban J, Jacewicz MS.

J Infect Dis. 1996 May;173(5):1164-70.

PMID:
8627068
49.

Detection of Shiga-Like Toxin-Producing Escherichia coli in Ground Beef and Milk by Commercial Enzyme Immunoassay.

Acheson DWK, Lincicome LL, DE Breucker S, Keusch GT.

J Food Prot. 1996 Apr;59(4):344-349. doi: 10.4315/0362-028X-59.4.344.

PMID:
31158989
50.

Regulation of the Shiga-like toxin II operon in Escherichia coli.

Mühldorfer I, Hacker J, Keusch GT, Acheson DW, Tschäpe H, Kane AV, Ritter A, Olschläger T, Donohue-Rolfe A.

Infect Immun. 1996 Feb;64(2):495-502.

Supplemental Content

Loading ...
Support Center